/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

E

Eric S. Daar

UCLA Medical Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

478

Papers

18.6K

Citations

66

h-index

231

i10-index

Eric S. Daar is an academic researcher from UCLA Medical Center. The author has contributed to research in topics: HIV Research and Treatment & HIV/AIDS Research and Interventions & HIV/AIDS drug development and treatment. The author has an h-index of 66, co-authored 407 publications.

ORCID: 0000-0003-1880-7331

Research Topics

HIV Research and Treatment HIV/AIDS Research and Interventions HIV/AIDS drug development and treatment HIV-related health complications and treatments SARS-CoV-2 and COVID-19 Research

Papers by this author

works

Clinical targeting of HIV capsid protein with a long-acting small molecule

2020 · Nature · 392 citations

https://doi.org/10.1038/s41586-020-2443-1

John O. Link Martin S. Rhee Winston C. Tse Jim Zheng

Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial

2018 · The Lancet HIV · 168 citations

https://doi.org/10.1016/s2352-3018(18)30091-2

Eric S. Daar Edwin DeJesus Peter Ruane Gordon Crofoot

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

2021 · The Lancet HIV · 88 citations

https://doi.org/10.1016/s2352-3018(21)00071-0

Onyema Ogbuagu Peter Ruane Daniel Podzamczer Laura Salazar

Changes in Fat Mitochondrial DNA and Function in Subjects Randomized to Abacavir-Lamivudine or Tenofovir DF–Emtricitabine With Atazanavir-Ritonavir or Efavirenz: AIDS Clinical Trials Group Study A5224s, Substudy of A5202

2012 · The Journal of Infectious Diseases · 55 citations

https://doi.org/10.1093/infdis/jis720

Grace A. McComsey Eric S. Daar MaryAnn O’Riordan Ann C. Collier

Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART

2014 · Journal of NeuroVirology · 37 citations

https://doi.org/10.1007/s13365-014-0246-6

Jaroslaw Harezlak Ronald A. Cohen Assawin Gongvatana Matthew Taylor

High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I

2022 · AIDS · 36 citations

https://doi.org/10.1097/qad.0000000000003244

Paul E. Sax Kristen Andreatta Jean‐Michel Molina Eric S. Daar

Research topics

topics

HIV Research and Treatment

HIV/AIDS Research and Interventions

HIV/AIDS drug development and treatment

HIV-related health complications and treatments

SARS-CoV-2 and COVID-19 Research

Chat about Author

Papers

Chat

Click to start Chat